Inherited predisposition to chronic lymphocytic leukemia

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Inherited susceptibility to chronic lymphocytic leukemia (CLL) is a recognized risk factor, accounting for approximately 10% of cases.
• Familial CLL shares similarities with sporadic CLL, but may present with a more indolent course, indicated by immunoglobulin heavy-chain variable region somatic hypermutation.
• Monoclonal B-cell lymphocytosis (MBL) is a newly identified precursor to CLL, prevalent in the general population and enriched in relatives of familial CLL patients.

Purpose of the Study:

• To explore the genetic underpinnings of familial chronic lymphocytic leukemia (CLL).
• To understand the role of genetic predisposition in CLL pathogenesis.
• To identify novel genetic loci associated with familial CLL.

Main Methods:

• Review of studies on familial CLL and monoclonal B-cell lymphocytosis (MBL).
• Analysis of mouse models of CLL.
• Application of systematic genomics approaches to familial CLL cases.

Main Results:

• Familial CLL may exhibit a more indolent disease course compared to sporadic CLL.
• Monoclonal B-cell lymphocytosis (MBL) is a likely precursor and is found in unaffected relatives of familial CLL patients.
• Identification of genes predisposing to familial CLL has been challenging due to small family sizes and likely polygenic inheritance.

Conclusions:

• Further genomic studies are expected to identify novel genetic loci involved in familial CLL.
• Understanding MBL and utilizing mouse models can enhance insights into early CLL pathogenesis related to familial predisposition.
• Genetic predisposition is a significant, yet complex, factor in CLL development.